Bioprocess Bags Market Size, Share & Trends Analysis Report By Type (2D Bioprocess Bags, 3D Bioprocess Bags, Others), By Application (Upstream Process, Downstream Process, Process Development), By End-User (Pharmaceutical & Biopharmaceutical Companies, Contract Manufacturing Organization, Academic & Research Institutions) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Bioprocess Bags Market Size

The global bioprocess bags market size was valued at USD 4.82 billion in 2025 and is projected to grow from USD 5.63 billion in 2026 to USD 19.50 billion by 2034, registering a CAGR of 16.8% during the forecast period from 2026 to 2034. North America dominated the bioprocess bags market with a market share of 38.4% in 2025.

Bioprocess bags are sterile, flexible containers used in the biotechnology, pharmaceutical, and life sciences sectors to store, process, and transport biological materials like cells, proteins, vaccines, blood products, and other biopharmaceutical substances. They are designed to maintain the integrity and sterility of their contents throughout production stages such as fermentation, cell culture, and storage, typically made from materials compatible with specific biological products.

A key factor fueling market growth is the rising demand for biologics, biosimilars, and advanced therapies like cell and gene therapies. Bioprocess bags provide an efficient, sterile, and scalable solution to these needs. In November 2024, Sartorius Stedim Biotech’s new Centre for Bioprocess Innovation in Marlborough, Massachusetts, exemplified the ongoing advancements in bioprocessing. This center fosters collaboration and the integration of Sartorius’s latest technologies, driving innovation and enhancing bioprocessing efficiency.

Technological advancements, such as real-time monitoring sensors and high-barrier films, continue to improve process efficiency and product safety. Moreover, the increasing presence of contract manufacturing organizations (CMOs) and academic research institutions is further propelling demand for scalable and disposable bioprocessing solutions. As material science continues to innovate, and with more investment flowing into biopharmaceutical R&D, new opportunities are emerging for market expansion.

Type

The 3D bioprocess bags segment leads the market due to their larger volume capacity, enhanced scalability, and improved mixing efficiency. These bags are ideal for large-scale biopharmaceutical production, particularly in biologics and vaccine manufacturing. Their structural design ensures better liquid handling, reduces contamination risks, and is highly compatible with advanced single-use bioreactors. These advantages make 3D bioprocess bags essential for optimizing production processes in the biopharmaceutical industry.

Request Customizationto receive a tailored report.

By Applications

The upstream process segment holds the largest share in the global market due to its widespread use in media preparation, cell culture expansion, and fermentation. The growing adoption of single-use bioreactors and disposable bioprocessing systems in biopharmaceutical manufacturing further drives demand. Upstream processes require scalable, sterile, and contamination-free solutions, making bioprocess bags vital for maintaining process efficiency and product integrity in biologics and vaccine production.

By End-User

Pharmaceutical and biopharmaceutical companies are the leading end-users in the market, driven by the increasing demand for biologics, biosimilars, and advanced therapies like cell and gene therapies. These companies are adopting single-use bioprocess bags to improve production efficiency, minimize contamination risks, and support flexible manufacturing operations. The expansion of biopharmaceutical manufacturing facilities and increased investment in biologics production further accelerates growth.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America holds a leading position in the global bioprocess bags market due to its robust biopharmaceutical manufacturing capabilities, high adoption of single-use technologies, and increasing investments in biologics and gene therapy production. The region’s presence of major biopharma companies, along with well-established regulatory frameworks and technological advancements in bioprocessing, drives market growth. Moreover, the region benefits from growing R&D activities, the expansion of large-scale biomanufacturing facilities, and strategic partnerships between industry players and research institutions, further boosting market dominance.

U.s. Bioprocess Bags Market Trends

The U.S. is a leader in the bioprocess bags market due to its high levels of investment in R&D in the country. In November 2024, AstraZeneca increased its full-year sales outlook due to strong demand for cancer and rare disease drugs and announced a $3.5 billion investment to expand its U.S. research and manufacturing footprint by 2026. This expansion is expected to drive the demand for advanced bioprocessing solutions, including bioprocess bags, in the region.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific is expected to register the fastest CAGR due to the rapid expansion of biopharmaceutical manufacturing, increasing investments in biosimilars and vaccines, and rising demand for cost-effective single-use bioprocessing solutions. Countries such as China, India, and South Korea are witnessing significant growth in contract manufacturing organizations (CMOs) and biologics production, further boosting the demand for bioprocess bags. Moreover, government initiatives supporting local biopharma infrastructure and the emergence of new market players contribute to regional growth.

India’s bioprocess bags industry is experiencing rapid growth, fueled by the expansion of the biotechnology sector. The number of biotech startups reached approximately 6,000 by 2023, driving significant demand for bioprocessing solutions, including bioprocess bags. India’s growing capabilities in biologics production and advanced therapies are propelling the need for scalable, efficient bioprocessing technologies, positioning the country as a key market for bioprocess bags.

China’s market is rapidly expanding, driven by increased government support for biotech innovation and the growth of biopharmaceutical manufacturing. The country’s push for self-sufficiency in biomanufacturing, coupled with the establishment of advanced production facilities, is fueling the demand for bioprocess bags. Moreover, the rising demand for biologics and biosimilars continues to accelerate market growth, making China a critical player in bioprocess bags.

Japan is witnessing significant growth in its market, underpinned by investments in biopharmaceutical research and a focus on regenerative medicine. The country’s well-established pharmaceutical industry, combined with government initiatives to support biomanufacturing advancements, is driving the adoption of single-use technologies. Japan’s commitment to biotechnology innovation and its expanding biotech infrastructure are key contributing factors.

Company Market Share

Key players in the industry are focusing on adopting key business strategies such as strategic collaborations, product approvals, acquisitions, and product launches to gain a strong foothold in the market. In addition to these, companies are investing in research and development to innovate and improve bioprocessing technologies, ensuring product reliability and efficiency.

Thermos Fisher Scientific Inc.: An Emerging Player in the Market

Thermo Fisher Scientific Inc. is rapidly emerging as a key player in the global bioprocess bags market, driven by its commitment to innovation and comprehensive portfolio of bioprocessing solutions. The company has expanded its offerings to include advanced single-use bioprocess bags designed for cell culture, fermentation, and other critical biomanufacturing applications.

Recent Developments by Thermo Fisher Scientific Inc.:

• In August 2024, Thermo Fisher Scientific Inc. opened its largest single-use technology manufacturing site in Greater Nashville. The USD 105 million, 400,000-square-foot facility will help meet the rising demand for bioprocessing materials used in vaccine and cancer therapy production. This site is part of Thermo Fisher’s USD 650 million multi-year investment to expand its bioprocessing production capabilities.

List of Key and Emerging Players in Bioprocess Bags Market